Document is current

Any future updates will be listed below

Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs

Crossref DOI link: https://doi.org/10.1007/s12325-019-00912-x

Published Online: 2019-03-12

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark